Literature DB >> 15180538

Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).

A O Vassilev1, F M Uckun.   

Abstract

BTK (Bruton's tyrosine kinase) is a member of the TEC family of tyrosine kinases that plays a central but diverse modulatory role in various cellular processes. The unique role of BTK in a multitude of signaling pathways, its function as a dual regulator of apoptosis and its involvement in a number of developmental processes makes BTK a desirable target for potential anti-cancer, anti-inflammatory and anti-viral agents as well as other treatments. The biochemistry and signaling networks of BTK were well described in numerous detailed reviews written by members of our team and others before us. Therefore in this particular review we are going to concentrate on the possible practical application of previously obtained knowledge to specific diseases and disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180538     DOI: 10.2174/1381612043384475

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer.

Authors:  Leila Kokabee; Xianhui Wang; Christopher J Sevinsky; Wei Lin Winnie Wang; Lindsay Cheu; Sridar V Chittur; Morteza Karimipoor; Martin Tenniswood; Douglas S Conklin
Journal:  Cancer Biol Ther       Date:  2015-09-18       Impact factor: 4.742

2.  A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.

Authors:  Cheryl Eifert; Xianhui Wang; Leila Kokabee; Antonis Kourtidis; Ritu Jain; Michael J Gerdes; Douglas S Conklin
Journal:  Genes Chromosomes Cancer       Date:  2013-08-03       Impact factor: 5.006

3.  Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.

Authors:  Xianhui Wang; Jason Wong; Christopher J Sevinsky; Leila Kokabee; Faiza Khan; Yan Sun; Douglas S Conklin
Journal:  Mol Cancer Ther       Date:  2016-06-02       Impact factor: 6.261

4.  Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer.

Authors:  Zhen Zhu; Lanlan Ling; Lezhong Qi; Yue Chong; Li Xue
Journal:  Onco Targets Ther       Date:  2020-05-13       Impact factor: 4.147

5.  A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries.

Authors:  Angelika Oehmig; Andrea Klotzbücher; Maria Thomas; Frank Weise; Ursula Hagner; Ralf Brundiers; Dirk Waldherr; Andreas Lingnau; Achim Knappik; Michael H G Kubbutat; Thomas O Joos; Hansjürgen Volkmer
Journal:  BMC Genomics       Date:  2008-09-24       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.